Skip to Main Content

Paper Details

An update on emerging drugs in osteosarcoma: towards tailored therapies?
Expert Opin Emerg Drugs
45
2019
HGOS, bone tumor, high-grade osteosarcoma, osteosarcoma, patients, rare, tumor
Author NameAffiliation
Claudia Maria HattingerPharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli
Claudia Maria HattingerPharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli
Massimo SerraPharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli
Massimo SerraPharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli
  • 1 - 4

Datasets

Release 1.2